- Headquarters
- Leverkusen, Germany · Europe
- Value chain
- Medicines & vaccines(Products); also Chemicals & gases
- What that means
- Develops and sells therapeutics under its own name: drugs, biologics, vaccines, cell and gene therapies and radiopharmaceuticals.
- Founded
- 1863
- Ownership
- Listed
- Listing
- ETR:BAYN on Google Finance
- Website
- bayer.com
- Relevance
- Very high at its strongest, in Synthetic Biology & Genetic Engineering
Leverkusen, GermanyIn 2 capabilities
Each capability the company is listed in, most relevant first: how experts in the field see its global relevance there, why it is listed and the source.
Biotechnology & Health Technologies · Research · listed #16 of 50
Global leader in genetically engineered crop traits (ex-Monsanto) now pursuing gene-edited crops, and co-founder of the Joyn Bio microbial engineering venture with Ginkgo.
Relevance: Global leader in GM crop traits (ex-Monsanto)
Biotechnology & Health Technologies · Design · listed #19 of 50
Markets Xofigo (radium-223), the first approved alpha-emitting therapy, and runs a targeted alpha and actinium-225 radiopharmaceutical pipeline.
Relevance: Markets first alpha-emitter therapy Xofigo